News & Media

Parallel and Ceres Acquisition Corp. Announce Business Combination to Create a Publicly Traded U.S. Cannabis Well-Being Company
Transaction expected to fuel the growth of Parallel’s U.S. footprint and enhance its mission to pioneer well-being and improve quality of life through cannabinoids
Surterra Texas™ Launches First Medical Cannabis Gummies for the Texas Compassionate Use Program
New cannabis-infused gummies provide Texas patients with conveniently-administered doses of THC and CBD for conditions such as terminal cancer, spasticity, autism, epilepsy, and incurable neurological diseases
NETA Awards $25,000 Security Equipment Grant to Social Equity Applicant Cannabis Delivery Service in Massachusetts
Twin Brothers Support NETA's Social Responsibility Vision
Surterra Wellness Unveils its New Heights Brand and Three New Coral Reefer Products Offering a Broad Selection of Edible and Sublingual Cannabis Products
Retail locations across Florida now have five innovative new product formats and flavors on shelves with exclusive promotions for customers
NETA Announces Security Equipment Grant Program to Reduce Financial Barriers for Economic Empowerment and Social Equity Cannabis Businesses
Leading Massachusetts cannabis company to donate $25,000 to two qualifying applicants
Parallel and Cannaclusive Announce Nationwide Partnership to Drive Social Equity Initiatives in the Cannabis Industry
Parallel, one of the largest privately-held multi-state cannabis operators in the United States (U.S.), today announced its national partnership with Cannaclusive, the leading organization created to facilitate inclusion for both business owners and consumers in the cannabis industry.
Surterra Texas™ Launches First Medical Cannabis Lotions for the Texas Compassionate Use Program
New cannabis-infused lotions provide Texas patients with convenient topical doses of THC and CBD for conditions such as spasticity, multiple sclerosis, terminal cancer, and ALS
Surterra Texas™ Launches First Medical Cannabis Lozenges for the Texas Compassionate Use Program
New cannabis-infused lozenges provide Texas patients with convenient sublingual doses of THC and CBD for conditions such as terminal cancer, spasticity, autism, epilepsy, and incurable neurological diseases.